Article
CDH1 c-160a promotor polymorphism is not associated with risk of stomach cancer.
International journal of cancer - 10 Sept 2002
Pharoah Paul D P, Oliveira Carla, Machado José Carlos, Keller Gisella, Vogelsang Holger, Laux Holger, Becker Karl-Friedrich, Hahn Heidi, Paproski Suzanne M, Brown Lindsay A, Caldas Carlos, Huntsman David
Abstract excerpt
We have combined data from case control studies designed to test the hypothesis that the c-160a promotor polymorphism in the gene coding for the cell adhesion molecule E-cadherin (CDH1) is associated with stomach cancer. A total of 899 individuals (433 patients and 466 controls) were analyzed. The genotype frequencies did not differ significantly between cases and controls, and the genotype-specific risks were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
